| Valproic acid | Approved Investigational | ANKK1 | 255239 |
downregulated | Valproic Acid results in decreased expression of ANKK1 mRNA | 11q23.2 | |
| Valproic acid | Approved Investigational | ANKLE1 | 126549 |
upregulated | Valproic Acid results in increased expression of ANKLE1 mRNA | 19p13.11 | |
| Valproic acid | Approved Investigational | ANKMY2 | 57037 |
upregulated | Valproic Acid results in increased expression of ANKMY2 mRNA | 7p21.1 | |
| Valproic acid | Approved Investigational | ANKRA2 | 57763 |
downregulated | Valproic Acid results in decreased expression of ANKRA2 mRNA | 5q13.2 | |
| Valproic acid | Approved Investigational | ANKRD1 | 27063 |
upregulated | Valproic Acid results in increased expression of ANKRD1 mRNA | 10q23.31 | |
| Valproic acid | Approved Investigational | ANKRD10 | 55608 |
downregulated | Valproic Acid results in decreased expression of ANKRD10 mRNA | 13q34 | |
| Valproic acid | Approved Investigational | ANKRD11 | 29123 |
upregulated | Valproic Acid results in increased expression of ANKRD11 mRNA | 16q24.3 | |
| Valproic acid | Approved Investigational | ANKRD12 | 23253 |
downregulated | Valproic Acid results in decreased expression of ANKRD12 mRNA | 18p11.22 | |
| Valproic acid | Approved Investigational | ANKRD13A | 88455 |
upregulated | Valproic Acid results in increased expression of ANKRD13A mRNA | 12q24.11 | |
| Valproic acid | Approved Investigational | ANKRD13B | 124930 |
downregulated | Valproic Acid results in decreased expression of ANKRD13B mRNA | 17q11.2 | |
| Valproic acid | Approved Investigational | ANKRD13C | 81573 |
upregulated | Valproic Acid results in increased expression of ANKRD13C mRNA | 1p31.1 | |
| Valproic acid | Approved Investigational | ANKRD18A | 253650 |
upregulated | Valproic Acid results in increased expression of ANKRD18A mRNA | 9p13.1 | |
| Valproic acid | Approved Investigational | ANKRD22 | 118932 |
upregulated | Valproic Acid results in increased expression of ANKRD22 mRNA | 10q23.31 | |
| Valproic acid | Approved Investigational | ANKRD28 | 23243 |
downregulated | Valproic Acid results in decreased expression of ANKRD28 mRNA | 3p25.1 | |
| Valproic acid | Approved Investigational | ANKRD33B | 651746 |
upregulated | Valproic Acid results in increased expression of ANKRD33B mRNA | 5p15.2 | |
| Valproic acid | Approved Investigational | ANKRD35 | 148741 |
downregulated | Valproic Acid results in decreased expression of ANKRD35 mRNA | 1q21.1 | |
| Valproic acid | Approved Investigational | ANKRD36 | 375248 |
downregulated | Valproic Acid results in decreased expression of ANKRD36 mRNA | 2q11.2 | |
| Valproic acid | Approved Investigational | ANKRD36B | 57730 |
upregulated | Valproic Acid results in increased expression of ANKRD36B mRNA | 2q11.2 | |
| Valproic acid | Approved Investigational | ANKRD37 | 353322 |
downregulated | Valproic Acid results in decreased expression of ANKRD37 mRNA | 4q35.1 | |
| Valproic acid | Approved Investigational | ANKRD44 | 91526 |
upregulated | Valproic Acid results in increased expression of ANKRD44 mRNA | 2q33.1 | |
| Valproic acid | Approved Investigational | ANKRD46 | 157567 |
upregulated | Valproic Acid results in increased expression of ANKRD46 mRNA | 8q22.3 | |
| Valproic acid | Approved Investigational | ANKRD50 | 57182 |
downregulated | Valproic Acid results in decreased expression of ANKRD50 mRNA | 4q28.1 | |
| Valproic acid | Approved Investigational | ANKRD54 | 129138 |
upregulated | Valproic Acid results in increased expression of ANKRD54 mRNA | 22q13.1 | |
| Valproic acid | Approved Investigational | ANKRD6 | 22881 |
downregulated | Valproic Acid results in decreased expression of ANKRD6 mRNA | 6q15 | |
| Valproic acid | Approved Investigational | ANKRD6 | 22881 |
upregulated | Valproic Acid results in increased expression of ANKRD6 mRNA | 6q15 | |